Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 26.51%3.09B | -36.88%2.44B | 44.65%716M | -79.74%459M | -46.25%387M | 125.00%882M | 20.85%3.87B | 13.79%495M | 29.35%2.27B | 40.35%720M |
| Cost of revenue | -17.24%1.89B | -7.09%2.28B | 73.25%693M | -30.88%752M | -37.33%423M | 41.72%411M | 24.45%2.45B | 20.48%400M | 18.91%1.09B | 87.50%675M |
| Gross profit | 630.91%1.21B | -88.37%165M | -75.79%23M | -124.79%-292M | -180.00%-36M | 365.35%470M | 15.18%1.42B | -6.86%95M | 40.74%1.18B | -70.59%45M |
| Operating expense | -17.16%927M | -11.33%1.12B | -14.04%147M | -34.65%298M | 13.75%364M | -1.59%310M | 6.77%1.26B | 50.00%171M | 26.32%456M | -6.71%320M |
| Staff costs | -0.78%255M | -40.78%257M | ---- | ---- | ---- | ---- | -2.03%434M | ---- | ---- | ---- |
| Other operating expenses | -22.04%672M | 4.11%862M | ---- | ---- | ---- | ---- | 12.04%828M | ---- | ---- | ---- |
| Operating profit | 129.25%279M | -707.64%-954M | -63.16%-124M | -181.72%-590M | -45.45%-400M | 174.77%160M | 214.00%157M | -533.33%-76M | 51.68%722M | -44.74%-275M |
| Net non-operating interest income (expenses) | -2.18%-375M | -12.23%-367M | -26.60%-238M | 6.52%-43M | 6.52%-43M | 8.51%-43M | 38.42%-327M | 45.66%-188M | 24.59%-46M | 24.59%-46M |
| Non-operating interest income | -50.00%2M | -20.00%4M | -50.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | -44.44%5M | 0.00%2M | -50.00%1M | -66.67%1M |
| Non-operating interest expense | -1.89%364M | 11.75%371M | 25.79%239M | -6.38%44M | -6.38%44M | -8.33%44M | -38.52%332M | -45.40%190M | -25.40%47M | -26.56%47M |
| Total other finance cost | --13M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | 1,535.71%229M | -58.82%14M | -80.00%1M | 2M | 0 | 11M | -48.48%34M | 350.00%5M | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | 0 | 0 | -88.75%9M | -69.23%4M | 0 | |||
| Income from associates and other participating interests | 1M | 0 | ||||||||
| Special income (charges) | 28,250.00%563M | -2M | -2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Less:Other special charges | -30,850.00%-615M | --2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | --52M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 33.33%8M | -33.33%6M | -42.86%4M | 0.00%1M | 200.00%9M | 600.00%7M | 0.00%1M | 0 | ||
| Income before tax | 153.87%703M | -944.00%-1.31B | -48.36%-362M | -188.87%-631M | -37.50%-440M | 147.23%128M | -129.98%-125M | -144.04%-244M | 44.02%710M | 9.60%-320M |
| Income tax | 4,160.00%213M | -88.89%5M | 102.22%1M | -97.73%2M | 0.00%1M | 0.00%1M | 1,025.00%45M | -4,600.00%-45M | 8,900.00%88M | -66.67%1M |
| Net income | 137.33%489M | -666.08%-1.31B | -81.50%-363M | -201.44%-632M | -37.27%-442M | 146.69%127M | -141.50%-171M | -136.23%-200M | 26.11%623M | 9.80%-322M |
| Net income continuous operations | 137.40%490M | -670.59%-1.31B | -82.41%-363M | -201.77%-633M | -37.38%-441M | 146.69%127M | -141.16%-170M | -135.99%-199M | 25.91%622M | 10.08%-321M |
| Noncontrolling interests | -77.12%89M | 216.26%389M | 800.00%63M | 78.18%98M | 0 | 228M | -68.70%123M | -102.93%-9M | -21.43%55M | 1,183.33%77M |
| Net income attributable to the company | 123.53%400M | -476.27%-1.7B | -122.40%-427M | -228.52%-730M | -11.03%-443M | 63.24%-100M | -1,652.63%-295M | -178.05%-192M | 33.96%568M | -9.92%-399M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 123.53%400M | -476.27%-1.7B | -122.40%-427M | -228.52%-730M | -11.03%-443M | 63.24%-100M | -1,652.63%-295M | -178.05%-192M | 33.96%568M | -9.92%-399M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 119.72%18.94 | -475.37%-96.03 | -121.80%-24.11 | -228.23%-41.2 | -10.95%-25.02 | 62.99%-5.7 | -1,631.19%-16.69 | -178.09%-10.87 | 34.21%32.13 | -10.22%-22.55 |
| Diluted earnings per share | 119.72%18.94 | -475.37%-96.03 | -121.89%-24.1197 | -228.52%-41.2351 | -10.97%-25.0235 | 62.99%-5.7 | -1,645.37%-16.69 | -178.23%-10.87 | 34.02%32.0842 | -9.98%-22.55 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |